RESUMO
As many studies are exploring the association between ingestion of bioactive compounds and decreased risk of non-communicable diseases, the scientific community continues to show considerable interest in these compounds. In addition, as many non-nutrients with putative health benefits are reducing agents, hydrogen donors, singlet oxygen quenchers or metal chelators, measurement of antioxidant activity using in vitro assays has become very popular over recent decades. Measuring concentrations of total phenolics, flavonoids, and other compound (sub)classes using UV/Vis spectrophotometry offers a rapid chemical index, but chromatographic techniques are necessary to establish structure-activity. For bioactive purposes, in vivo models are required or, at the very least, methods that employ distinct mechanisms of action (i.e., single electron transfer, transition metal chelating ability, and hydrogen atom transfer). In this regard, better understanding and application of in vitro screening methods should help design of future research studies on 'bioactive compounds'.
Assuntos
Antioxidantes/análise , Flavonoides/análise , Fenóis/análise , Antioxidantes/química , Quelantes/química , Cromatografia Líquida de Alta Pressão , Flavonoides/química , Humanos , Metais/química , Fenóis/química , Espectrofotometria , Relação Estrutura-AtividadeRESUMO
The normal degree of intra- and interindividual variation in gene transcription profiles of healthy human tissues has not been extensively investigated. In the study described here, microarrays were employed to analyze gene transcription in peripheral blood mononuclear cells prepared from serial blood samples that had been obtained, at weekly intervals, from apparently healthy human volunteers. Transcript levels for the majority of genes examined were found to be remarkably consistent within samples from a single donor. Conversely, marked differences were observed in samples obtained from different donors. Genes that exhibited differential expression dependent on sex, age, body mass index, and the presence of varying proportions of different leukocyte subsets were identified. These results emphasize the important contributions of genetic and environmental factors, as well as varying representation of different cell types, in determining the overall gene transcriptional profiles of human tissues. However, the study also provides evidence that, within an individual, the gene transcription profiles of sampled tissues can be comparatively stable over time.
Assuntos
Perfilação da Expressão Gênica , Regulação da Expressão Gênica , Variação Genética , Leucócitos Mononucleares/metabolismo , Adulto , Análise por Conglomerados , Feminino , Citometria de Fluxo , Expressão Gênica , Humanos , Leucócitos/metabolismo , Masculino , Pessoa de Meia-Idade , Modelos Estatísticos , Análise de Sequência com Séries de Oligonucleotídeos , RNA Mensageiro/metabolismo , Fatores SexuaisAssuntos
Antioxidantes/farmacologia , Dieta , União Europeia/organização & administração , Pesquisa/organização & administração , Animais , Anticarcinógenos/administração & dosagem , Anticarcinógenos/farmacologia , Anticarcinógenos/uso terapêutico , Antioxidantes/administração & dosagem , Antioxidantes/uso terapêutico , Doenças Cardiovasculares/prevenção & controle , Ensaios Clínicos como Assunto , Métodos Epidemiológicos , Europa (Continente) , Comportamento Alimentar , Análise de Alimentos , Humanos , Modelos Biológicos , Neoplasias/prevenção & controle , Estresse Oxidativo/efeitos dos fármacos , Plantas Comestíveis/química , Espécies Reativas de Oxigênio/metabolismoAssuntos
Antioxidantes/farmacocinética , Animais , Ácido Ascórbico/farmacocinética , Disponibilidade Biológica , Carotenoides/farmacocinética , Alimentos , Glucosinolatos/farmacocinética , Glutationa/farmacocinética , Humanos , Absorção Intestinal , Especificidade de Órgãos , Fenóis/farmacocinética , Selênio/farmacocinética , Distribuição Tecidual , Vitamina E/farmacocinéticaAssuntos
Antioxidantes/farmacologia , Regulação da Expressão Gênica/efeitos dos fármacos , Mitocôndrias/efeitos dos fármacos , Nitrogênio/metabolismo , Espécies Reativas de Oxigênio/metabolismo , Animais , Transporte de Elétrons/efeitos dos fármacos , Humanos , Peroxidação de Lipídeos , Camundongos , Camundongos Transgênicos , Mitocôndrias/fisiologia , Oxirredução , Processamento de Proteína Pós-Traducional/efeitos dos fármacos , Processamento de Proteína Pós-Traducional/fisiologia , Ratos , Transdução de Sinais/efeitos dos fármacos , Transdução de Sinais/fisiologia , Compostos de Sulfidrila/química , Fatores de Transcrição/metabolismo , Ativação TranscricionalAssuntos
Biomarcadores , Aminoácidos/química , Animais , Antioxidantes/farmacologia , Bioquímica/métodos , DNA/química , DNA/efeitos dos fármacos , Adutos de DNA/análise , Dano ao DNA , Humanos , Peroxidação de Lipídeos/efeitos dos fármacos , Oxidantes/farmacologia , Oxirredução , Estresse Oxidativo , Proteínas/química , Proteínas/efeitos dos fármacosRESUMO
The HDL (high-density lipoprotein)-associated enzyme PON (paraoxonase)-1 protects LDL (low-density lipoprotein) from oxidative modification in vitro, although it is unknown if this anti-atherogenic action occurs in vivo. In a cross-sectional study of 58 Type II diabetic subjects and 50 controls, we examined the fasting plasma LDL basal conjugated diene concentration [a direct measurement of circulating oxLDL (oxidatively modified LDL)], lipoprotein particle size by NMR spectroscopy, PON-1 polymorphisms (coding region polymorphisms Q192R and L55M, and gene promoter polymorphisms -108C/T and -162G/A), PON activity (with paraoxon or phenyl acetate as the substrates) and dietary antioxidant intake. Plasma oxLDL concentrations were higher in Type II diabetic patients (males, P = 0.048; females, P = 0.009) and unrelated to NMR lipoprotein size, PON-1 polymorphisms or PON activity (with paraoxon as the substrate) in any group. In men with Type II diabetes, however, there was a direct relationship between oxLDL concentrations and PON activity (with phenyl acetate as the substrate; r = 0.611, P = 0.0001) and an atherogenic NMR lipid profile in those who were PON-1 55LL homozygotes. Circulating oxLDL concentrations in vivo were unrelated to PON-1 genotypes or activity, except in male Type II diabetics where there was a direct association between PON activity (with phenyl acetate as the substrate) and oxLDL levels. These in vivo data contrast with in vitro data, and may be due to confounding by dietary fat intake. Male Type II diabetic subjects with PON-1 55LL homozygosity have an atherogenic NMR lipid profile independent of LDL oxidation. These data do not support an in vivo action of PON on LDL oxidation.
Assuntos
Arildialquilfosfatase/genética , Diabetes Mellitus Tipo 2/metabolismo , Lipoproteínas LDL/sangue , Adulto , Idoso , Antioxidantes/análise , Arildialquilfosfatase/metabolismo , Estudos de Casos e Controles , Estudos Transversais , Dieta , Feminino , Humanos , Lipídeos/sangue , Espectroscopia de Ressonância Magnética , Masculino , Pessoa de Meia-Idade , Tamanho da Partícula , Regiões Promotoras Genéticas , Análise de RegressãoRESUMO
Epidemiological evidence has shown that the habitual consumption of diets high in fruits and vegetables is associated with reduced risk of cancers. The challenge is to identify causal mechanisms of effect. The aim of the current study was to determine whether an increase in rate of removal of DNA single-strand breaks (SSB) following oxidative challenge could be provoked ex vivo in peripheral blood lymphocytes (PBL). The PBL were isolated from apparently healthy volunteers following dietary intervention with: (1) a mixed carotene capsule; (2) a daily portion of cooked minced carrots; (3) a matched placebo; (4) a portion of mandarin oranges; (5) vitamin C tablets. Single-cell gel electrophoresis was employed to measure baseline levels of SSB and DNA susceptibility to oxidative damage, and to monitor the number of SSB over 4 h, in both unchallenged and H2O2-treated PBL. The enzymatic capacity for repair of different types of DNA oxidative lesions was also measured using two related cell-free assays. There was no evidence that any of the dietary supplementation regimens altered baseline levels of SSB, provided any direct antioxidant protection or altered DNA repair capacity, with two exceptions: the number of SSB following exposure to H2O2 decreased more rapidly in PBL from volunteers given the mixed carotene capsules and repair patch synthesis activity in PBL increased from volunteers given the cooked carrots. These results suggest that carotenoids and carotenoid-rich foods can influence DNA damage:repair by modulation of discrete stages in the DNA repair mechanisms.
Assuntos
Antioxidantes/administração & dosagem , Carotenoides/administração & dosagem , Dano ao DNA/efeitos dos fármacos , Reparo do DNA , Suplementos Nutricionais , Linfócitos/efeitos dos fármacos , beta Caroteno/análogos & derivados , Adolescente , Adulto , Anticarcinógenos/sangue , Antioxidantes/análise , Carotenoides/sangue , Criptoxantinas , Dano ao DNA/genética , DNA de Cadeia Simples/genética , Humanos , Masculino , Pessoa de Meia-Idade , Oxirredução/efeitos dos fármacos , Tocoferóis/sangue , Xantofilas , beta Caroteno/sangueRESUMO
Dietary antioxidants, such as the carotenoids, may protect DNA from oxidative damage. This has been proposed to explain the epidemiological association between higher consumption of fruits and vegetables, which are rich in antioxidants, and lower incidence of cancer. However, this remains to be demonstrated conclusively. The effects of carotenoid supplementation on 1) baseline DNA damage, 2) susceptibility of cellular DNA to oxidative attack, and 3) DNA repair were measured in the human lymphocyte cell line Molt-17. Baseline DNA damage, susceptibility to oxidant attack (100 mumol/l H2O2 for 5 min at 4 degrees C), and disappearance of DNA single-strand breaks (SSB) after oxidative challenge were monitored by single-cell gel electrophoresis. DNA repair patch synthesis activity in cell extracts was determined using assays that measure nucleotide incorporation during repair of oxidative lesions in template DNA. Unlike single-cell gel electrophoresis, the parameters measured with these assays are not dependent on strand break religation. There was no evidence that beta-carotene, lutein, or beta-cryptoxanthin supplementation protected cellular DNA from oxidation under basal conditions or after oxidative challenge. However, only carotenoid-supplemented cells exhibited a significant decrease in numbers of SSB over a 2-h period after treatment with H2O2. Carotenoid supplementation did not provoke any detectable change in repair patch synthesis activity. We conclude that supplementation with carotenoids at 8 mumol/l does not provide significant antioxidant protection for DNA in Molt-17 lymphocytes but may enhance recovery of cells from oxidative challenge, as measured by loss of SSB. We argue that these data are most consistent with carotenoids acting to enhance DNA strand break repair.
Assuntos
Antioxidantes/administração & dosagem , Carotenoides/administração & dosagem , Dano ao DNA , Reparo do DNA , Linfócitos/efeitos dos fármacos , Antioxidantes/metabolismo , Carotenoides/metabolismo , Células Cultivadas , Ensaio Cometa/métodos , Humanos , Peróxido de Hidrogênio/efeitos adversos , Cinética , Lipossomos , Linfócitos/metabolismo , OxirreduçãoRESUMO
Reports on the effects of carotenoids are conflicting. The present paper examines similarities and differences from contiguous studies in vitro and in vivo. Single-cell gel electrophoresis was used to measure the frequency of single-strand breaks (SSB) in the cell line MOLT-17 (as a model system) and human peripheral blood lymphocytes (PBL). MOLT-17 cells were supplemented with beta-carotene, lutein or lycopene at a range of concentrations (0.00-8.00 micromol/l) using a liposome delivery method. Uptake was dose-dependent. beta-Carotene concentration in the media had no effect on SSB in control cells, but incubation with lycopene or lutein (>2.00 micromol/l) increased the numbers of SSB in control cells. MOLT-17 DNA was less susceptible to oxidative damage (100 micromol H2O2/l, 5 min, 4 degrees C) following incubation with carotenoids between 0.50 and 1.00 micromol/l; at >1.00 micromol/l the effects were ambiguous. Apparently healthy male volunteers supplemented their habitual diets with lutein, beta-carotene or lycopene (natural isolate capsules, 15 mg/d, 4 weeks) in three independent studies, raising plasma concentrations to different extents. Lycopene and lutein had no effect on SSB in control PBL or following oxidative challenge. However, increased plasma beta-carotene was associated with more SSB in control cells whilst PBL DNA resistance to oxidative damage ex vivo was unaffected. These results suggest that the carotenoids are capable of exerting two overlapping but distinct effects: antioxidant protection by scavenging DNA-damaging free radicals and modulation of DNA repair mechanisms.